Trademark: 78705641
Word
PARVULET
Status
Dead
Status Code
710
Status Date
Friday, May 3, 2019
Serial Number
78705641
Registration Number
4215867
Registration Date
Tuesday, October 2, 2012
Mark Type
4000
Filing Date
Thursday, September 1, 2005
Published for Opposition
Tuesday, June 2, 2009
Cancellation Date
Friday, May 3, 2019

Trademark Owner History
ADARE PHARMACEUTICALS, INC. -
EGALET LTD - Original Registrant
EGALET A-S - Owner At Publication

Classifications
5 Pharmaceutical and veterinary preparations for the treatment of pain relief and pain management, shock, hemorrhage and bleeding, pre- and post-operative complications in the nature of hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions, respiratory and circulatory crises and dysfunctions, cognitive dysfunctions, fibrosis, infections, fever and sepsis, and traumas and emergencies, namely, fractures, abrasions, burns, psychological and immunological shock, poisons and pollutions, animal bites or stings, fever, respiratory and cardiovascular shock, crises and dysfunctions, and hemorrhage, bleeding, thrombosis, emboli, stroke, apoplexy, lesions and cognitive dysfunctions, and physical and psychological substance dependence, namely, drug and alcohol dependence, drug tolerance, withdrawal symptoms, convulsions, Alzheimer disease, dementias, Parkinson's disease, insufficient saliva and inability to swallow, allergy/immunology disorders, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases in the nature of flu, AIDS/HIV, anthrax, plague, cholera, biological infections, and prion exposure, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, genitourinary diseases and afflictions, premature labor, poison exposure, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; dietetic food adapted for medical use; diagnostic preparations for medical and veterinary use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; synthetic peptides for pharmaceutical purposes; vitamins; biomedical compounds, namely, peptide substrates for use in analyzing and detecting toxins for medical laboratory use; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets, oral liquids, oral gels, and oral emulsions for the continuous release of a wide variety of therapeutic agents within a certain time after ingestion; medicated candy; medicated chewing gum; breath-freshening chewing gum for medical purposes; medicated lollipops; sweets for medicinal purposes, namely, sweets containing pharmaceutical and medical substances and compounds
10 Surgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery apparatus and instruments in the form of containers for various pharmaceuticals, drugs, medicines, compounds and substances in the form of liquids, gels, grains, emulsions, blister packs and sachets; spoons, cups and syringes for administering pharmaceutical substances and medicines; drug delivery systems
40 Treatment of materials, namely, milling, mixing, grinding, liquefying, pulverizing, melting and extrusion of medical and pharmaceutical substances, compounds and materials
42 Scientific research; technology consultation in the field of scientific research; design for others in the fields of pain relief and pain management, pharmaceutical drug and medicine development, development of medicines and medicine goods and packaging in the fields of traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, occupational diseases and afflictions, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear-nose and throat, diseases and afflictions on the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, veterinary preparations for the treatment of bovine, sheep, horses, pigs, poultry, ostrich, rodents, dogs, cats, camels, donkeys, elephants; chemical, biochemical, biological and bacteriological research and analysis; pharmaceutical drug and medicine development services; design for others in the field of drugs and medicines; development of pharmaceutical preparations and medicines; professional consultancy pertaining to pharmacology, namely, biotechnical and biomedical and medical and pharmaceutical substances, preparations and compounds; professional consultancy in the field of research and development of medicine and the dispensing of pharmaceutical preparations; pharmaceutical drug development services comprised of scientific, industrial, technological, bio technical, pharmaceutical, biomedical and clinical research in the field of drugs and drug candidates; medical and scientific research, namely, conducting clinical trials of new drug candidates; consultation in the field of scientific research pertaining to chemical, pharmaceutical and medical goods; design for others in the field of medical packaging and equipment; development of pharmaceutical preparations and medicines; consultation in the field of biotechnological and biomedical scientific research; biochemical and molecular biological analyses; in vitro and in vivo preclinical tests and clinical tests of drug candidates and potential drugs; consultancy and research regarding pharmaceuticals in gel-like and viscous liquid dosage forms; consultancy and research pertaining to pharmacology in the nature of alternative drugs for the young, elderly and those with difficulties swallowing pills and tablets; development of in vitro and in vivo preclinical tests of drug candidates and potential drugs; biochemical and molecular biological analyses; scientific, industrial, technological and biotechnological analysis in the field of pharmaceutical and veterinary drug and medicine analysis, analysis of drug delivery apparatus and containers, analysis of synthetic peptides for pharmaceutical purposes, analysis of peptide substrates, analysis for the purpose of detecting various toxins, analysis of drug candidates and potential drugs

Trademark Events
Jul 31, 2019
Automatic Update Of Assignment Of Ownership
May 3, 2019
Cancelled Sec. 8 (6-Yr)
Oct 2, 2017
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 14, 2016
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 14, 2016
Teas Change Of Owner Address Received
Oct 2, 2012
Registered-Principal Register
Aug 29, 2012
1(B) Basis Deleted; Proceed To Registration
Aug 15, 2012
Notice Of Allowance Cancelled
Aug 15, 2012
Teas Delete 1(B) Basis Received
Feb 22, 2012
Notice Of Approval Of Extension Request E-Mailed
Feb 21, 2012
Extension 5 Granted
Feb 10, 2012
Extension 5 Filed
Feb 10, 2012
Teas Extension Received
Aug 23, 2011
Notice Of Approval Of Extension Request E-Mailed
Aug 20, 2011
Extension 4 Granted
Aug 17, 2011
Extension 4 Filed
Aug 17, 2011
Teas Extension Received
Feb 26, 2011
Notice Of Approval Of Extension Request E-Mailed
Feb 25, 2011
Extension 3 Granted
Feb 23, 2011
Extension 3 Filed
Feb 23, 2011
Teas Extension Received
Oct 13, 2010
Automatic Update Of Assignment Of Ownership
Sep 9, 2010
Notice Of Approval Of Extension Request E-Mailed
Sep 8, 2010
Extension 2 Granted
Aug 23, 2010
Extension 2 Filed
Aug 23, 2010
Teas Extension Received
Jan 30, 2010
Extension 1 Granted
Dec 21, 2009
Extension 1 Filed
Jan 29, 2010
Case Assigned To Intent To Use Paralegal
Dec 21, 2009
Teas Extension Received
Aug 25, 2009
Noa Mailed - Sou Required From Applicant
Jun 2, 2009
Published For Opposition
May 13, 2009
Notice Of Publication
Apr 28, 2009
Law Office Publication Review Completed
Apr 27, 2009
Approved For Pub - Principal Register
Apr 4, 2009
Teas/Email Correspondence Entered
Apr 4, 2009
Correspondence Received In Law Office
Apr 1, 2009
Teas Response To Office Action Received
Oct 8, 2008
Notification Of Non-Final Action E-Mailed
Oct 8, 2008
Non-Final Action E-Mailed
Oct 8, 2008
Non-Final Action Written
Sep 12, 2008
Teas/Email Correspondence Entered
Sep 12, 2008
Correspondence Received In Law Office
Sep 11, 2008
Teas Change Of Correspondence Received
Sep 11, 2008
Teas Response To Office Action Received
Mar 11, 2008
Notification Of Non-Final Action E-Mailed
Mar 11, 2008
Non-Final Action E-Mailed
Mar 11, 2008
Non-Final Action Written
Feb 6, 2008
Teas/Email Correspondence Entered
Feb 5, 2008
Correspondence Received In Law Office
Feb 5, 2008
Teas Response To Suspension Inquiry Received
Nov 26, 2007
Notification Of Inquiry As To Suspension E-Mailed
Nov 26, 2007
Inquiry To Suspension E-Mailed
Nov 26, 2007
Suspension Inquiry Written
Nov 6, 2007
Lie Checked Susp - To Atty For Action
May 4, 2007
Report Completed Suspension Check Case Still Suspended
May 4, 2007
Assigned To Lie
Oct 25, 2006
Letter Of Suspension E-Mailed
Oct 25, 2006
Suspension Letter Written
Oct 3, 2006
Teas Change Of Correspondence Received
Oct 3, 2006
Teas/Email Correspondence Entered
Oct 2, 2006
Correspondence Received In Law Office
Oct 2, 2006
Teas Response To Office Action Received
Mar 30, 2006
Non-Final Action E-Mailed
Mar 30, 2006
Non-Final Action Written
Mar 16, 2006
Assigned To Examiner
Feb 27, 2006
Teas/Email Correspondence Entered
Feb 15, 2006
Correspondence Received In Law Office
Feb 15, 2006
Teas Voluntary Amendment Received
Sep 9, 2005
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24